Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study

Fig. 4

Peritoneal and serum 1.3 beta-d-glucan to rule out intra-abdominal candidiasis in secondary peritonitis. Receiver operating characteristic curve of peritoneal and serum 1.3 beta-d-glucan for identification of intra-abdominal candidiasis (A—peritoneal BDG (n = 196)/B—serum BDG at Day 1 according to the test used (Wako test® N = 42 and Fungitell® beta-d-glucan assay N = 140). Abbreviations: FA: Fungitell® beta-d-glucan assay (Associate of Cape Cod, East Falmouth, Inc., United States of America); pBDG: peritoneal 1.3 beta-d-glucan; sBDG: serum 1.3 beta-d-glucan; WT: Wako® beta-glucan test (Fujifilm Wako Chemicals Europe, Neuss, Germany)

Back to article page

Critical Care

ISSN: 1364-8535